The loss of ER expression in about one-fourth of recurrent oestrogen receptor-positive (ER+) breast cancer makes them immune to endocrine therapy and able to spread unchecked.
from mint - Science https://ift.tt/omh8bO6
https://ift.tt/6uLSKpI
from mint - Science https://ift.tt/omh8bO6
https://ift.tt/6uLSKpI
إرسال تعليق